As of 2025-05-14, the Relative Valuation of Rhythm Pharmaceuticals Inc (RYTM) is (169.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 56.79 USD, the upside of Rhythm Pharmaceuticals Inc based on Relative Valuation is -397.7%.
The range of the Relative Valuation is (146.13) - (195.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.2x - 31.9x | 24.5x |
| Forward P/E multiples | 23.1x - 31.0x | 29.0x |
| Fair Price | (146.13) - (195.68) | (169.07) |
| Upside | -357.3% - -444.6% | -397.7% |
| Date | P/E |
| 2025-05-12 | -9.32 |
| 2025-05-09 | -9.08 |
| 2025-05-08 | -9.61 |
| 2025-05-07 | -10.23 |
| 2025-05-06 | -9.92 |
| 2025-05-05 | -10.19 |
| 2025-05-02 | -10.13 |
| 2025-05-01 | -10.09 |
| 2025-04-30 | -10.31 |
| 2025-04-29 | -10.32 |
| 2025-04-28 | -10.19 |
| 2025-04-25 | -10.09 |
| 2025-04-24 | -9.96 |
| 2025-04-23 | -9.47 |
| 2025-04-22 | -9.37 |
| 2025-04-21 | -9.57 |
| 2025-04-17 | -9.77 |
| 2025-04-16 | -9.71 |
| 2025-04-15 | -9.82 |
| 2025-04-14 | -9.52 |
| 2025-04-11 | -9.42 |
| 2025-04-10 | -9.15 |
| 2025-04-09 | -9.53 |
| 2025-04-08 | -9.13 |
| 2025-04-07 | -8.70 |
| 2025-04-04 | -7.43 |
| 2025-04-03 | -7.88 |
| 2025-04-02 | -8.22 |
| 2025-04-01 | -7.91 |
| 2025-03-31 | -8.38 |
| 2025-03-28 | -8.67 |
| 2025-03-27 | -8.46 |
| 2025-03-26 | -8.59 |
| 2025-03-25 | -8.37 |
| 2025-03-24 | -8.50 |
| 2025-03-21 | -8.23 |
| 2025-03-20 | -8.58 |
| 2025-03-19 | -8.74 |
| 2025-03-18 | -8.27 |
| 2025-03-17 | -8.28 |
| 2025-03-14 | -8.06 |
| 2025-03-13 | -7.95 |
| 2025-03-12 | -8.12 |
| 2025-03-11 | -7.92 |
| 2025-03-10 | -7.68 |
| 2025-03-07 | -8.04 |
| 2025-03-06 | -8.17 |
| 2025-03-05 | -8.38 |
| 2025-03-04 | -8.42 |
| 2025-03-03 | -8.29 |